Eledon Pharmaceuticals, Inc. financial statements
Eledon Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 45.62M | 10-K |
| Cash and equivalents | USD 22.81M | 10-Q |
| Total debt | USD 0 | 10-K |
Eledon Pharmaceuticals, Inc. financials on 6ix · Eledon Pharmaceuticals, Inc. on 6ix